Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 4
Submit an article Journal homepage
337
Views
13
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and leukocytosis

Amir T. FathiMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
,
Frederic I. PrefferMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Hossein SadrzadehMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Karen K. BallenMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Philip C. AmreinMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Eyal C. AttarMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Steven L. McAfeeMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Laura DillonMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
,
Yi-Bin ChenMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
&
Robert P. HasserjianMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
 show all
Pages 860-863 | Received 27 Jul 2012, Accepted 06 Sep 2012, Published online: 28 Sep 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Amir T. Fathi & Yi-Bin Chen. (2014) CD30: a new target for ALL?. Leukemia & Lymphoma 55:3, pages 478-479.
Read now
Wenli Zheng, L. Jeffrey Medeiros, Ken H. Young, Maitrayee Goswami, Linda Powers, Hagop H. Kantarjian, Deborah A. Thomas, Jorge E. Cortes & Sa A. Wang. (2014) CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis. Leukemia & Lymphoma 55:3, pages 624-627.
Read now
Ashkan Emadi & Judith E. Karp. (2013) CD30 in myeloid malignancies: hitting the bull's-eye with an available dart. Leukemia & Lymphoma 54:4, pages 679-680.
Read now

Articles from other publishers (10)

Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 301 427 .
Rupa Narayan, Traci M. Blonquist, Ashkan Emadi, Robert P. Hasserjian, Meghan Burke, Christopher Lescinskas, Donna S. Neuberg, Andrew M. Brunner, Gabriela Hobbs, Hanno Hock, Steven L. McAfee, Yi‐Bin Chen, Eyal Attar, Timothy A. Graubert, Christina Bertoli, Jenna A. Moran, Meghan K. Bergeron, Julia E. Foster, Aura Y. Ramos, Tina T. Som, Megan K. Vartanian, Jennifer L. Story, Kristin McGregor, Molly Macrae, Tanya Behnan, Margaret C. Wey, Jessica Rae, Frederic I. Preffer, Patricia Lesho, Vu H. Duong, Mason L. Mann, Karen K. Ballen, Christine Connolly, Philip C. Amrein & Amir T. Fathi. (2019) A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia. Cancer 126:6, pages 1264-1273.
Crossref
Mina L. Xu, Ali Gabali, Eric D. Hsi, Yuri Fedoriw, Kiran Vij, Mohamed E. Salama, Radhakrishnan Ramchandren, Dennis O’Malley, Mark R. Wick, Maxime Battistella & Alejandro A. Gru. (2020) Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis. American Journal of Surgical Pathology 44:2, pages e1-e14.
Crossref
Yuxin Liu, Jan Philipp Bewersdorf, Maximilian Stahl & Amer M. Zeidan. (2019) Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?. Blood Reviews 34, pages 67-83.
Crossref
Olakunle Ogunrinade, David Terrano, April Chiu & Melissa Pulitzer. (2017) CD30 Expression Is Rare in Myeloid Leukemia Cutis: A Study of 55 Cases and Implications for Routine Diagnostic Algorithms. The American Journal of Dermatopathology 39:5, pages 351-357.
Crossref
S S Hoseini & N K Cheung. (2017) Acute myeloid leukemia targets for bispecific antibodies. Blood Cancer Journal 7:2, pages e522-e522.
Crossref
Geetika Bhatt, Kami Maddocks & Beth Christian. (2016) CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas. Current Hematologic Malignancy Reports 11:6, pages 480-491.
Crossref
Ofir Wolach & Richard M. Stone. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research 89 100 .
Kuei-Fang Lee, Julia Tzu-Ya Weng, Paul Wei-Che Hsu, Yu-Hsiang Chi, Ching-Kai Chen, Ingrid Y. Liu, Yi-Cheng Chen & Lawrence Shih-Hsin Wu. (2014) Gene Expression Profiling of Biological Pathway Alterations by Radiation Exposure. BioMed Research International 2014, pages 1-9.
Crossref
Elihu Estey. (2013) Are immunoconjugates approaching ?standard of care? in AML?. Best Practice & Research Clinical Haematology 26:3, pages 261-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.